Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2026-01-24 @ 6:59 PM
Study NCT ID:
NCT04853368
Status:
TERMINATED
Last Update Posted:
2024-07-16
First Post:
2021-04-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-05
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-19
First Submit QC Date:
None
Study First Post Date:
2021-04-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-03
Results First Submit QC Date:
None
Results First Post Date:
2024-07-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-15
Last Update Post Date:
2024-07-16
Last Update Post Date Type:
ACTUAL